This was consistent with previous studies implicating dysfunction of the NPY system in various inflammatory pathologies, including cardiovascular disease, and neuroendocrine tumors through distinct signaling pathways via their receptors (Y1R, Y5R)57,58,129–131. Here, NPY is linked to cardiovascular disorder.